Capital International Investors Moderna, Inc. Transaction History

Capital International Investors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $56.6 Million - $93.1 Million	-559,020 Reduced 87.74%	78,116 $9.28 Million
Q1 2024 May 14, 2024	BUY	$85.37 - $115.44 $1.99 Million - $2.69 Million	23,286 Added 3.79%	637,136 $67.9 Million
Q4 2023 Feb 13, 2024	SELL	$69.51 - $104.43 $486 - $731	-7 Reduced -0.0%	613,850 $61 Million
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $1.32 Million - $1.74 Million	-13,743 Reduced 2.19%	613,857 $63.4 Million
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $86.3 Million - $117 Million	-728,177 Reduced 53.71%	627,600 $76.3 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $184 Million - $267 Million	1,355,777 New	1,355,777 $208 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

Stay updated on Capital International Investors with notifications on news.